Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

NEW YORK — December 22, 2025 — Goldman Sachs Group, Inc. (The) (NYSE: GS) is ending 2025 with its stock hovering near the top of its yearly range, fueled by renewed confidence in global dealmaking, steady client activity across market cycles, and a growing narrative that productivity gains from AI could lift profitability further in 2026. By midday trading on Monday, GS shares were around $903, up roughly 1% on the session, after moving between the high-$890s and low-$900s. Barchart.com With the bank’s next earnings release scheduled for Thursday, January 15, 2026, investors now face a familiar late-year tension: Goldman’s
Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard Incorporated (NYSE: MA) is starting the week in focus after a fresh wave of payments-industry headlines put the company’s long-term growth narrative—digital commerce, tokenization, B2B payments, and AI-enabled checkout—back in the spotlight. As of Dec. 22, 2025 (17:00 UTC), Mastercard stock was trading around $576.90, up about 0.8% on the day, after touching an intraday high near $579.40. Below is a detailed look at what’s driving the conversation around MA stock today, the most important catalysts investors are watching, and how current forecasts and analyst expectations are shaping the risk/reward setup into 2026. Mastercard stock price action: what investors
AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie Inc. (NYSE: ABBV) is trading near recent highs on Monday, December 22, 2025, as investors weigh a powerful mix of policy risk, shareholder returns, and pipeline momentum heading into 2026. The big near-term variable isn’t a clinical readout—it’s Washington. After the White House unveiled sweeping “most-favored-nation” (MFN) drug-pricing agreements with nine large manufacturers on December 19, AbbVie remains one of the last major drugmakers still outside the deal. The White House+1 At the same time, AbbVie’s core fundamentals continue to be anchored by its immunology franchise—Skyrizi and Rinvoq—alongside a rising dividend profile and a pipeline that includes late-stage programs
Cytokinetics (CYTK) Stock Hits 52-Week High as FDA Approval of Myqorzo Triggers Analyst Price-Target Hikes

Cytokinetics (CYTK) Stock Hits 52-Week High as FDA Approval of Myqorzo Triggers Analyst Price-Target Hikes

Cytokinetics, Incorporated (NASDAQ: CYTK) surged on Monday, December 22, 2025, extending a sharp rally that followed the company’s first-ever U.S. drug approval. Shares traded around $69.68 in the session, up roughly 11% from the prior close, after reaching an intraday high near $70.86—a move that pushed the biotech to fresh 52-week highs and re-focused Wall Street on the commercial potential of its newly approved heart drug, Myqorzo (aficamten). Investing.com The immediate catalyst is straightforward: the U.S. Food and Drug Administration approved Myqorzo on December 19, 2025 for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). But the market reaction on December
Citigroup Stock Hits a Fresh 52-Week High as Regulators Ease Oversight and Wall Street Updates 2026 Outlook

Citigroup Stock Hits a Fresh 52-Week High as Regulators Ease Oversight and Wall Street Updates 2026 Outlook

Dec. 22, 2025 — Citigroup Inc. (NYSE: C) is ending the year with momentum. In Monday trading, Citigroup stock pushed to a new 52‑week high and traded around $118, extending a powerful 2025 rally that has been driven by a mix of turnaround execution, capital return, and—most recently—regulatory overhang starting to lift. Investing.com+1 For investors trying to separate signal from noise, today’s Citi story is less about a single headline and more about a cluster of developments that collectively support the “simplification + risk-control repair + returns” thesis CEO Jane Fraser has been selling for years—now with outside validation from
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Inc. (NASDAQ: AMGN) is back in the spotlight on Monday, December 22, 2025, as investors weigh a wave of White House drug‑pricing agreements, a fast‑moving “most‑favored‑nation” (MFN) pricing push, and what it could all mean for Amgen’s earnings power in 2026. The stock traded higher in Monday’s session, with market data showing shares around $331. While the headlines are centered on drug prices, the market’s reaction has been notably measured: several analyst notes published today suggest these deals may be designed to reduce political and tariff uncertainty more than they materially compress pharma profits—at least in the near term.
Quantum Computing Inc (QUBT) Stock News Today: Why Shares Jumped on Dec. 22, 2025 — and What Analysts Forecast Next

Quantum Computing Inc (QUBT) Stock News Today: Why Shares Jumped on Dec. 22, 2025 — and What Analysts Forecast Next

Quantum Computing Inc. (Nasdaq: QUBT) is back in the spotlight on Monday, Dec. 22, 2025, after a sharp intraday rally that highlights both the promise—and the peril—of the public “pure-play quantum” trade. As of the latest available trade data Monday, QUBT was around $12.39, up roughly 13.8% on the day, after opening near $10.93 and trading between $10.86 and $12.54. Trading volume topped 17 million shares, underscoring how quickly sentiment can swing in this name. So what’s driving the move, what did the latest company filings actually say, and how are analysts framing the stock heading into 2026? What happened
Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing, Inc. (NASDAQ: RGTI) is back in the spotlight on Monday, December 22, 2025, as quantum-computing stocks regain momentum. RGTI traded around $27 in Monday’s session, up roughly 14% on the day—another reminder that quantum “pure plays” can move fast in both directions. Finviz The renewed attention isn’t coming from a single headline. Instead, it’s being driven by a dense cluster of fresh stock-focused commentary published today—including a Zacks deep dive into estimates and valuation, a TipRanks roundup of what Wall Street expects for 2026, and a Motley Fool/Nasdaq comparison of Rigetti versus IonQ. Finviz+2TipRanks+2 Below is a detailed
Firefly Aerospace Stock (NASDAQ: FLY) Jumps on Russell Index Addition: Today’s News, Analyst Forecasts, and Lawsuit Updates (Dec. 22, 2025)

Firefly Aerospace Stock (NASDAQ: FLY) Jumps on Russell Index Addition: Today’s News, Analyst Forecasts, and Lawsuit Updates (Dec. 22, 2025)

Firefly Aerospace Inc. (NASDAQ: FLY) stock is back in the spotlight on December 22, 2025, with shares trading around $28 and posting a mid-session gain of roughly 14% after hitting an intraday high near $28.30 on elevated volume. Investing.com The day’s action is being shaped by two very different forces: a visibility-boosting index milestone (Firefly’s addition to major Russell indexes) and a renewed wave of securities-litigation headlines circulating across newswires. Together, they’re amplifying both attention and volatility—exactly the kind of mix that can make a young, newly public aerospace name move fast in either direction. Why Firefly Aerospace stock is
Qualcomm (QCOM) Stock News Today: Alphawave Semi Deal, Analyst Targets, and the Biggest 2026 Catalysts

Qualcomm (QCOM) Stock News Today: Alphawave Semi Deal, Analyst Targets, and the Biggest 2026 Catalysts

December 22, 2025 — QUALCOMM Incorporated (NASDAQ: QCOM) stock is trading modestly higher in Monday’s session, as investors weigh a fresh batch of deal headlines and Wall Street target updates against a bigger question: can Qualcomm’s diversification story (AI data centers, AI PCs, automotive, edge) keep accelerating as smartphone growth normalizes? Below is a detailed, publication-ready roundup of the latest QCOM stock news, forecasts, and analyses available as of 22.12.2025, with a focus on what matters most for the next 6–12 months. QCOM stock price check: where Qualcomm shares stand on Dec. 22 Qualcomm shares were last indicated around $175
Hut 8 Stock (HUT) Jumps on Benchmark’s Street-High $85 Target as $7 Billion AI Data Center Deal Re-Rates the Story

Hut 8 Stock (HUT) Jumps on Benchmark’s Street-High $85 Target as $7 Billion AI Data Center Deal Re-Rates the Story

Hut 8 Corp. (Nasdaq: HUT; TSX: HUT) is back in the spotlight on Monday, December 22, 2025, as the company’s shares extend a sharp rally tied to its pivot from crypto-native infrastructure toward AI and high-performance computing (HPC) data centers. The latest catalyst: Benchmark raised its price target to a Street-high $85, arguing that Hut 8’s newly announced River Bend transaction marks a structural shift in the company’s revenue quality and durability. Investing.com+1 As of midday trading on Dec. 22, Hut 8 shares were up roughly 16% on the session, reflecting how quickly the market is repricing the company after
Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot stock (NYSE: HD) is trading modestly higher on Monday, December 22, 2025, as investors weigh a steady stream of analyst commentary against the company’s recently reset expectations for 2026—a year management expects to remain closely tied to housing-market momentum and the timing of a recovery in bigger-ticket renovation spending. As of the latest update Monday afternoon (UTC), Home Depot shares were around $347, up roughly 0.7% on the day, with the session ranging roughly from the mid-$343s to the high-$347s. Home Depot stock price check: where HD trades on Dec. 22, 2025 Home Depot’s share price is still

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop